• Shuttle Pharmaceuticals Holdings held its annual shareholder meeting on May 21, 2026.
• Shareholders ratified Forvis Mazars as independent auditor for the fiscal year ending Dec. 31, 2026.
• An advisory vote backed the pay packages for the company’s named executive officers.
• Shareholders authorized the board to pursue a reverse stock split within a 1-for-2 to 1-for-150 range; no split was confirmed as executed.
• Shareholders also authorized adjournment of the meeting, though it was not required.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-025340), on May 27, 2026, and is solely responsible for the information contained therein.